Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
4.120
+0.095 (2.36%)
Feb 21, 2025, 4:00 PM EST - Market closed
Sagimet Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 133 | 124 | - | - | - | - |
| Enterprise Value | -37 | 22 | - | - | - | - |
| Last Close Price | 4.12 | 5.42 | - | - | - | - |
| PS Ratio | - | 62.05 | - | - | - | - |
| PB Ratio | 0.78 | 1.36 | - | - | - | - |
| P/TBV Ratio | 0.52 | 1.36 | - | - | - | - |
| EV/Sales Ratio | - | 11.18 | - | - | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.04 |
| Asset Turnover | - | 0.03 | - | - | - | - |
| Quick Ratio | 37.26 | 16.78 | 6.13 | 23.25 | 35.97 | 4.92 |
| Current Ratio | 38.41 | 17.09 | 6.21 | 24.04 | 35.99 | 5.21 |
| Return on Equity (ROE) | -27.94% | -46.95% | -72.58% | -39.63% | -29.98% | - |
| Return on Assets (ROA) | -20.58% | -29.61% | -42.17% | -23.16% | -17.79% | - |
| Return on Capital (ROIC) | -21.27% | -32.29% | -45.89% | -23.93% | -18.65% | - |
| Earnings Yield | -28.28% | -22.46% | - | - | - | - |
| FCF Yield | -29.02% | -19.15% | - | - | - | - |
| Buyback Yield / Dilution | -527.36% | -5565.90% | -50.61% | -26.95% | - | - |
| Total Shareholder Return | -527.36% | -5565.90% | -50.61% | -26.95% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.